GSK vs KNSL · P/E 13, $103.31B cap vs P/E 13, rev $1.02B
GlaxoSmithKline PLC ADR (GSK) versus Kinsale Capital Group Inc (KNSL) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Kinsale Capital Group Inc (KNSL) is a insurance - property & casualty company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported KNSL revenue for 2026-06-30 was $1.02B. Net income was $288.4M. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. KNSL currently screens at market cap $7.06B and trailing P/E 13.5.
Not investment advice. Open the GSK and KNSL stock pages for the full models.
Not investment advice.